There's no question that for patients coping with a rare or complex disease or a compromised immune system, COVID-19 resulted in multiple new...
Entering our third year of coping with a pandemic that continues to disrupt lives brings into ever sharper focus the multiple difficulties involved for...
Maintaining, Monitoring, and Measuring a Smooth Patient Journey The journey of a rare disease patient is not an easy one from the start, frequently...
For more than 50 years, newborn screening for rare and congenital conditions has been part of healthcare in the United States. What began as a single...
From filling out an insurance form to interpreting nutrition labels, a patient's understanding of what they're reading and ability to use that...
Orsini is a leading independent national specialty pharmacy accredited by ACHC, JCAHO, URAC, and VIPPS. The services we provide allow patients, physicians, payors, and manufacturers to improve care, simplify processes, and achieve better outcomes.
Orsini Announcement: Orsini Specialty Pharmacy Chosen to Dispense YARGESA (miglustat)
Orsini selected as the exclusive specialty pharmacy for WAINUA (eplontersen) for adults with hereditary transthyretin-mediated amyloid polyneuropathy
Now In Stock: ADZYNMA (ADAMTS13, recombinant-krhn), for patients with cTTP
Orsini Specialty Pharmacy Selected as Distribution Partner for Adzynma (ADAMTS13, recombinant-krhn), a Newly Approved Treatment for an Ultra-Rare Blood Clotting Disorder
Orsini Specialty Pharmacy Partners with Amicus Therapeutics to Dispense New Therapy for the Treatment of Late-Onset Pompe Disease